Potential Funding Pathways for Medical Biotechnology
Agenda:
8:30 – 9:00 Participant registration
9:00 – 9:15 Opening, welcoming remarks – speeches
- Mr. Piotr Matczuk, President of the Management Board of PFR S.A., Polish Development Fund
- Mr. Zbysław Ziemacki, Director of the Department of Innovation and Space Policy, Ministry of Economic Development and Technology
- Mr. Grzegorz Rabsztyn, Director of the EIB Group Office in Poland
9:15 – 9:30 Ms. Marta Winiarska, President and Managing Director of the Polish Union of Innovative Medical Biotechnology Companies BioInMed
“Financing Innovative Projects in the Field of Medical Biotechnology – Opportunities and Challenges”
PART I – FUNDING PATHWAYS
The European Investment Bank’s Offer – BioTech EU Initiative
Speakers: Gergely Krajcsi, Hanna Nommik
Scope:
- Support for innovation – BioTechEU initiative
- Access to financing:
-
- Eligibility of companies for EIB financing
- Financing for clinical trials, initial production, and commercialization
- Financing structure (venture debt / quasi-equity)
- Application process and required documents
- Common mistakes made by companies
- Sample path: from VC rounds to bank financing
- Q&A session
Outcome: The company knows whether it is eligible to apply for EIB support and how to prepare.
10:00 – 10:30 European Innovation Council Fund – under the EIC Accelerator program
Speaker: Anna Stodołkiewicz
Scope:
- Support for innovation from the EIC Fund
- Access to funding:
- Company eligibility for EIC funding
- Funding for research and development, clinical trials, initial production, and commercialization
- Financing structure (equity)
- Application process and required documents
- Common mistakes made by companies
- Sample path: from research grants to VC funding rounds
- Q&A session
Outcome: The company knows whether it is eligible to apply for EIC support and how to prepare for it.
10:30 – 11:00 EIF / VC Funds – Financing Startups
Speaker: Zvonimir Ratkovski
Scope:
- How the EIB invests in VC funds (EIF)
- How to find the right fund in Europe
- Requirements of deep-tech / biotech investors
- How to join an international investor consortium
- Preparing for an international funding round
Outcome: The startup knows who to approach and how to enter the European investment ecosystem.
11:00 – 11:30 Coffee break
11:30 – 12:00 Domestic instruments – PFR and PFR Ventures
„VC Funds: Market Landscape, Practical Advice, and Educational and Networking Programs”
Scope:
Part I – PFR Ventures (Speaker: Piotr Kędra)
- Presentation of programs managed by PFR Ventures
- Presentation of VC funds that have benefited from PFR Ventures programs
- Brief description of VC funds’ collaboration with startups
Part II – VC Fund (Speakers: Marcin Bielówka, Ernest Wawryniuk)
- Presentation by a market practitioner (VC fund representative) and case study
Part III – VC Connect: PFR Future of Health (Speaker: Julia Klimiuk)
- Discussion of the VC Connect project organized by PFR, with a focus on the PFR Future of Health track
Outcome: The company understands how VC funds in the PFR Ventures portfolio operate and is familiar with PFR’s educational and networking programs
12:00 – 12:30 Q&A Session – PFR, PFR Ventures, VC Fund
PART II – INVESTMENT MATCHMAKING
12:30 – 1:30 Presentation Session I – Presentations by biotechnology companies and research teams
Format:
- Max. 5-minute presentation + technical break
- approx. 10 selected companies and research teams
- Participation of EIF/EIB funds, VC funds, funds cooperating with PFR, and funds specializing in company formation and very early-stage investments
Goal: Investors will review the project portfolio in one location.
1:30 PM – 3:00 PM BiotechVenture Cafe
- Networking session for all participants
For those interested:
- Table discussions – first meetings with investors
Format:
- Investor tables
- 1-on-1 conversations
Goal: direct networking conversations with investors
